Single nucleotide polymorphisms of CTLA4 gene and their association with human cervical cancer

Chinese Journal of Medical Genetics

Volumn 28, Issue 3, 2011, Pages 313-317

  Jiang, Li ^a   Luo, Ruo Yu ^a   Zhang, Wei ^a   Wang, Li Rong ^a   Wang, Fang ^a   Cheng, Yan Xiang ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Cervical cancer; Sequenom; Single nucleotide polymorphism

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; LUCIFERASE;

ALLELE; ARTICLE; ASSAY; CHINA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENE EXPRESSION; GENE LOCATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NORMAL HUMAN; POLYMORPHIC LOCUS; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER;

ADULT; AGED; ALLELES; ANTIGENS, CD; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 79959551538     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-9406.2011.03.017     Document Type: Article

References (15)

1. Moberg M, Gustavsson I, Gyllensten U. Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. Int J Cancer, 2004, 112:854-859. (Pubitemid 39435271)
2. Weidhaas JB, Li SX, Winter K, et al. Changes in gene expression predicting local control in cervical cancer, results from Radiation Therapy Oncology Group 0128. Clin Cancer Res, 2009, 15:4199-4206.
3. Apple RJ, Becker TM, Wheeler CM, et al. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma. J Natl Cancer Inst, 1995, 87:427-436.
4. Apple RJ, Erlich HA, Klitz W, et al. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet, 1994, 6:157-162. (Pubitemid 24188596)
5. Pandey SR, Mittal M, Srivastava K, et al. Impact of Toll-like receptors[TLR]2 (-196 to-174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women. Gynecol Oncol, 2009, 114:501-505.
6. Sharma SA, Sharma SK, Sharma B, et al. Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF-alpha levels. Am J Respir Cell Mol Biol, 2006, 35:488-495. (Pubitemid 44477649)
7. Singh HM, Jain B, Mittal B. Role of TGF-betal (-509C>T) promoter polymorphism in susceptibility to cervical cancer. Oncol Res, 2009, 18: 41-45.
8. Tian Q, Lu W, Chen H, et al. The nonsynonymous single-nucleotide polymorphisms in codon 31 of p21 gene and the susceptibility to cervical cancer in Chinese women. Int J Gynecol Cancer, 2009, 19:1011-1014.
9. Zhang BX, Pan GP, Anderson TA. MicroRNAs as oncogenes and tumor suppressors. Dev Biol, 2007, 302:1-12. (Pubitemid 46096921)
10. Zhang SX, Wu T, Jiang Y, et al. The up-regulation of KCC1 gene expression in cervical cancer cells by IGF-II through the ERK1/2MAPK and PI3K/AKT pathways and its significance. Eur J Gynaecol Oncol, 2009, 30:29-34.
11. Ivansson EL, Juko-Pecirep I, Gyllensten UB. Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer. Gynecol Oncol, 2008, 116:544-548.
12. Hu L, Liu J, Chen X, et al. CTLA4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers-hepatocellular carcinoma and cervical cancer. Hum Immunol, 2007, 71, 888-891.
13. Rahimifar S, Erfani N, Sarraf Z, et al. CTLA4 gene variations may influence cervical cancer susceptibility. Gynecol Oncol, 2010, 119:136-139.
14. Karabon L, Kosmaczewska A, Bilinska M, et al. The CTLA4 gene polymorphisms are associated with CTLA4 protein expression levels in multiple sclerosis patients and with susceptibility to disease. Immunology, 2009, 128:787-796.
15. Ligers A, Teleshova N, Masterman T, et al. CTLA4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun, 2001, 2:145-152. (Pubitemid 33674879)